ALPS Advisors’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-123,009
| Closed | -$439K | – | 1008 |
|
|
2024
Q3 | $439K | Buy |
123,009
+74,530
| +154% | +$266K | ﹤0.01% | 628 |
|
|
2024
Q2 | $301K | Buy |
48,479
+4,797
| +11% | +$29.7K | ﹤0.01% | 847 |
|
|
2024
Q1 | $412K | Buy |
43,682
+3,828
| +10% | +$36.1K | ﹤0.01% | 620 |
|
|
2023
Q4 | $269K | Buy |
+39,854
| New | +$269K | ﹤0.01% | 909 |
|
|
2023
Q2 | – | Sell |
-40,692
| Closed | -$116K | – | 1014 |
|
|
2023
Q1 | $116K | Buy |
40,692
+5,334
| +15% | +$15.2K | ﹤0.01% | 997 |
|
|
2022
Q4 | $257K | Buy |
+35,358
| New | +$257K | ﹤0.01% | 951 |
|